Publications
Nightingale Health’s technology is routinely used in world-class epidemiological and genetic studies. There are over 600 publications that have utilized our technology.
Highlighted publications
←
→
Metabolomic profiles predict individual multidisease outcomes
Buergel et al., Nat Med., 2022
Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank
Julkunen et al., Nat Commun., 2023
Genome-wide characterization of circulating metabolic biomarkers
Karjalainen et al., Nature, 2024
All
Ageing & dementia
Cancer
Cardiovascular disease
Diabetes
Exposome & nutrition
Genetics
Inflammation & immunity
Kidney disease
Liver disease
Lung disease
Maternal & child health
Medicines & trials
Methods
Mortality & multi-morbidity
Obesity & bodyweight
Psychiatric disorders
Risk prediction
Ageing & dementia, Genetics
Investigating Causal Relations Between Circulating Metabolites and Alzheimer’s Disease: A Mendelian Randomization Study
S. Huang et. al, Journal of Alzheimer's Disease, 2022
Ageing & dementia
Longitudinal analysis of UK Biobank participants suggests age and APOE-dependent alterations of energy metabolism in development of dementia
J. Liu et. al, 2022
Exposome & nutrition
Diverging metabolic effects of 2 energy-restricted diets differing in nutrient quality: a 12-week randomized controlled trial in subjects with abdominal obesity
S. Schutte et. al, The American Journal of Clinical Nutrition, 2022
Diabetes, Genetics
Genome-wide discovery for diabetes-dependent triglycerides-associated loci
M. Selvaraj et. al, PLOS ONE, 2022
Maternal & child health
Early life infection and proinflammatory, atherogenic metabolomic and lipidomic profiles in infancy: a population-based cohort study
T. Mansell et. al, eLife, 2022
J. Seah et. al, The Journal of Clinical Endocrinology & Metabolism, 2022
Obesity & bodyweight
Sex-specific associations of adiposity with cardiometabolic traits in the UK: A multi–life stage cohort study with repeat metabolomics
L. O’Keeffe et. al, PLOS Medicine, 2022
D. Hughes et. al, Bioinformatics, 2022
Medicines & trials, Genetics
Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation
T. Richardson et. al, PLOS Biology, 2022
Inflammation & immunity, Lung disease
Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment
A. Rendeiro et. al, Frontiers in Immunology, 2022
Liver disease, Genetics
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease
P. Luukkonen et. al, Journal of Hepatology, 2021
D. Bizzarri et. al, eBioMedicine, 2021
Cardiovascular disease, Risk prediction
Serum metabolomics improve risk stratification for incident heart failure
R. Oexner et. al, 2023
Mortality & multi-morbidity
From plasma triglycerides to triglyceride metabolism: effects on mortality in the Copenhagen General Population Study
M. Johansen et. al, European Heart Journal, 2023
Cardiovascular disease
Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study
E. Björnson et. al, European Heart Journal, 2023